Long known for its scientific software delivery expertise and technical staffing capability, Tessella is mounting a push to climb higher up the consultancy ladder…read more

Quick ‘bench-to-bedside’ clinical trial would enroll 1,400 influenza patients to test corticosteroids and statins as potential treatments
TORONTO, Ont., November 10, 2009 — An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. Read more ….

Estonia National Archives to use the latest version of Tessella technology to address the challenge of digital preservation.

Oxford, UK | 10 November 2009. Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments, is pleased to announce that the Estonia National Archives have selected Tessella SDB4, [...]

By Tom Parke
The US Food and Drug Administration (FDA) end-of-Phase 2a (EOP2A) meeting guidance issued on the September 2009 emphasises the value of the greater use of trial simulation and alternative design strategies in the clinical trials design process. The FDA’s primary purpose of an EOP2A meeting is to select the dosing regime and design [...]

Stephen Mounsey finds out about the computing power behind some of the world’s most ambitious scientific projects…read more

BOSTON, Nov. 2, 2009 (GLOBE NEWSWIRE) — AG Mednet, the world’s largest diagnostic imaging network, announced today that more than 2000 users around the world have been credentialed to access and use its electronic diagnostic image submission platform…read more

Life Science Leader Magazine – Erie,PA,USA
In 2004, the FDA unveiled a project called the Critical Path Initiative. As then Commissioner of Food and Drugs Andrew C. Von Eschenbach, M.D., later explained to Congress, “This project has the potential to transform the way medical products in the United States are designed, developed, tested, and used.” more